Advertisement
TWST Forex News
Twist Bioscience Inks Antibody Discovery, Option And License Deal With Bayer For Up To $188 Mln
Twist Bioscience Corp. (TWST) announced Thursday an antibody discovery, option and license agreement with Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L), under which Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to conduct antibody discovery campaigns against targets to be determined by Bayer.
RTTNews
|
639 days ago
Twist Bioscience Q3 Results Top Estimates
Genomics company Twist Bioscience Corp. (TWST) reported Friday a net loss attributable to common stockholders for the third quarter of $60.52 million or $1.08 per share, wider than $40.04 million or $0.82 per share in the prior-year quarter.
RTTNews
|
1065 days ago
